PubMed

Enhancement of blood-tumor barrier permeability by Sar-[D-Phe8]des-Arg9BK, a metabolically resistant bradykinin B1 agonist, in a rat C6 glioma model.

Cardoso RC, Lobão-Soares B, Bianchin MM, Carlotti CG Jr, Walz R, Alvarez-Silva M, Trentin AG, Nicolau M.

BMC Neurosci. 2004 Sep 30;5:38.PMID: 15458573 [PubMed - indexed for MEDLINE]Related articlesFree article

Cardiovascular effects of Sar-[D-Phe8]des-Arg9-bradykinin, a metabolically protected agonist of B1 receptor for kinins, in the anesthetized rabbit pretreated with a sublethal dose of bacterial lipopolysaccharide.

Audet R, Rioux F, Drapeau G, Marceau F.

J Pharmacol Exp Ther. 1997 Jan;280(1):6-15.PMID: 8996175 [PubMed - indexed for MEDLINE]Related articlesFree article

Plasma extravasation mediated by lipopolysaccharide-induction of kinin B1 receptors in rat tissues.

Wille PR, Vitor R, Gabilan NH, Nicolau M.

Mediators Inflamm. 2001 Jun;10(3):163-7.PMID: 11545253 [PubMed - indexed for MEDLINE]Related articlesFree article

Induction of bradykinin B1 hypotensive receptors in rats by lipopolysaccharide.

Nicolau M, Feltrin MR, Regoli D.

Can J Physiol Pharmacol. 1996 Mar;74(3):337-40.PMID: 8773415 [PubMed - indexed for MEDLINE]Related articles

Metabolically stable bradykinin B2 receptor agonists enhance transvascular drug delivery into malignant brain tumors by increasing drug half-life.

Sarin H, Kanevsky AS, Fung SH, Butman JA, Cox RW, Glen D, Reynolds R, Auh S.

J Transl Med. 2009 May 13;7:33.PMID: 19439100 [PubMed - indexed for MEDLINE]Related articlesFree article

Bradykinin increases permeability by calcium and 5-lipoxygenase in the ECV304/C6 cell culture model of the blood-brain barrier.

Easton AS, Abbott NJ.

Brain Res. 2002 Oct 25;953(1-2):157-69.PMID: 12384249 [PubMed - indexed for MEDLINE]Related articles

Overexpression of bradykinin type 2 receptors on glioma cells enhances bradykinin-mediated blood-brain tumor barrier permeability increase.

Uchida M, Chen Z, Liu Y, Black KL.

Neurol Res. 2002 Dec;24(8):739-46.PMID: 12500695 [PubMed - indexed for MEDLINE]Related articles

Bradykinin decreases T-kininogen synthesis in a rat hepatoma cell line: evidence of bradykinin B2-type receptors.

Raymond P, Bouvier M, Drapeau G, Blais C Jr, Morais R, Adam A.

Peptides. 1996;17(7):1171-6.PMID: 8959752 [PubMed - indexed for MEDLINE]Related articles

Unlocking the blood-brain barrier: a role for RMP-7 in brain tumor therapy.

Elliott PJ, Hayward NJ, Huff MR, Nagle TL, Black KL, Bartus RT.

Exp Neurol. 1996 Oct;141(2):214-24.PMID: 8812155 [PubMed - indexed for MEDLINE]Related articles

Synergistic effect of low-frequency ultrasound and low-dose bradykinin on increasing permeability of the blood-tumor barrier by opening tight junction.

Zhang Z, Xia C, Xue Y, Liu Y.

J Neurosci Res. 2009 Aug 1;87(10):2282-9.PMID: 19326437 [PubMed - indexed for MEDLINE]Related articles

The role of kinin B1 in the plasma extravasation of carrageenin-induced pleurisy.

Hayashi I, Amano H, Ishihara K, Kumagai Y, Yoshimura H, Majima MC.

Life Sci. 2002 Jan 11;70(8):937-49.PMID: 11853231 [PubMed - indexed for MEDLINE]Related articles

Intracarotid low dose bradykinin infusion selectively increases tumor permeability through activation of bradykinin B2 receptors in malignant gliomas.

Matsukado K, Sugita M, Black KL.

Brain Res. 1998 May 4;792(1):10-5.PMID: 9593802 [PubMed - indexed for MEDLINE]Related articles

Bradykinin-induced blood-brain tumor barrier permeability increase is mediated by adenosine 5'-triphosphate-sensitive potassium channel.

Zhang H, Gu YT, Xue YX.

Brain Res. 2007 May 4;1144:33-41. Epub 2007 Feb 8.PMID: 17331483 [PubMed - indexed for MEDLINE]Related articles

Early upregulation of kinin B1 receptors in retinal microvessels of the streptozotocin-diabetic rat.

Abdouh M, Khanjari A, Abdelazziz N, Ongali B, Couture R, Hasséssian HM.

Br J Pharmacol. 2003 Sep;140(1):33-40.PMID: 12967932 [PubMed - indexed for MEDLINE]Related articlesFree article

The development of the bradykinin agonist labradimil as a means to increase the permeability of the blood-brain barrier: from concept to clinical evaluation.

Emerich DF, Dean RL, Osborn C, Bartus RT.

Clin Pharmacokinet. 2001;40(2):105-23. Review.PMID: 11286321 [PubMed - indexed for MEDLINE]Related articles

Dexamethasone enhances adenosine 5'-triphosphate-sensitive potassium channel expression in the blood-brain tumor barrier in a rat brain tumor model.

Gu YT, Zhang H, Xue YX.

Brain Res. 2007 Aug 8;1162:1-8. Epub 2007 Jun 9.PMID: 17618607 [PubMed - indexed for MEDLINE]Related articles

Permeability of the blood brain barrier by the bradykinin agonist, RMP-7: evidence for a sensitive, auto-regulated, receptor-mediated system.

Bartus RT, Elliott P, Hayward N, Dean R, McEwen EL, Fisher SK.

Immunopharmacology. 1996 Jun;33(1-3):270-8.PMID: 8856161 [PubMed - indexed for MEDLINE]Related articles

Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies.

Bartus RT, Snodgrass P, Dean RL, Kordower JH, Emerich DF.

Exp Neurol. 2000 Jan;161(1):234-44.PMID: 10683290 [PubMed - indexed for MEDLINE]Related articles

Effects of dexamethasone and protein kinase C inhibitors on the induction of bradykinin B1 mRNA and the bradykinin B1 receptor-mediated contractile response in isolated rat ileum.

Ueno A, Dekura E, Kosugi Y, Yoshimura M, Naraba H, Kojima F, Oh-ishi S.

Biochem Pharmacol. 2002 Jun 1;63(11):2043-53.PMID: 12093482 [PubMed - indexed for MEDLINE]Related articles

Correlation between bradykinin-induced blood-tumor barrier permeability and B2 receptor expression in experimental brain tumors.

Liu Y, Hashizume K, Chen Z, Samoto K, Ningaraj N, Asotra K, Black KL.

Neurol Res. 2001 Jun;23(4):379-87.PMID: 11428519 [PubMed - indexed for MEDLINE]Related articles